Chimeric Therapeutics is trading A$0.01 (-14.29%) with no clear company-specific catalyst identified for September 21, 2026.

  • ASX’s September 21 announcement list showed no Chimeric Therapeutics filing.
  • Recent coverage concerns a September 18 share-quotation application, not a new September 21 event.
  • Broader U.S. markets were positive, so global sentiment does not clearly explain this decline.